| タイトル | Structural Basis for EGFR Mutant Inhibition by Trisubstituted Imidazole Inhibitors. |
|---|
| ジャーナル・号・ページ | J. Med. Chem., Vol. 63, Page 4293-4305, Year 2020 |
|---|
| 掲載日 | 2019年12月4日 (構造データの登録日) |
|---|
著者 | Heppner, D.E. / Gunther, M. / Wittlinger, F. / Laufer, S.A. / Eck, M.J. |
|---|
リンク | J. Med. Chem. / PubMed:32243152 |
|---|
| 手法 | X線回折 |
|---|
| 解像度 | 1.79 - 3.6 Å |
|---|
| 構造データ | PDB-6v5n: EGFR(T790M/V948R) in complex with LN2084 手法: X-RAY DIFFRACTION / 解像度: 2.4 Å PDB-6v5p: EGFR(T790M/V948R) in complex with LN2725 手法: X-RAY DIFFRACTION / 解像度: 2.3 Å PDB-6v66: EGFR(T790M/V948R) in complex with LN2899 手法: X-RAY DIFFRACTION / 解像度: 1.79 Å PDB-6v6k: EGFR(T790M/V948R) in complex with LN2057 手法: X-RAY DIFFRACTION / 解像度: 2.2 Å PDB-6v6o: EGFR(T790M/V948R) in complex with LN2380 手法: X-RAY DIFFRACTION / 解像度: 2.1 Å PDB-6vh4: Wild type EGFR in complex with LN2380 手法: X-RAY DIFFRACTION / 解像度: 2.8 Å PDB-6vhn: Wild type EGFR in complex with LN2057 手法: X-RAY DIFFRACTION / 解像度: 2.4 Å PDB-6vhp: Wild type EGFR in complex with LN2899 手法: X-RAY DIFFRACTION / 解像度: 3.6 Å |
|---|
| 化合物 | ChemComp-QP7: 3-[4-(4-fluorophenyl)-5-(2-phenyl-1H-pyrrolo[2,3-b]pyridin-4-yl)-1H-imidazol-2-yl]propan-1-ol
ChemComp-QP4: 4-[4-(4-fluorophenyl)-2-(3-methoxypropyl)-1H-imidazol-5-yl]-2-phenyl-3H-pyrrolo[2,3-b]pyridine
ChemComp-QP1: N-{3-[(4-{4-(4-fluorophenyl)-2-[(2-methoxyethyl)sulfanyl]-1H-imidazol-5-yl}pyridin-2-yl)amino]-4-methoxyphenyl}propanamide
ChemComp-QQJ: N-[3-({4-[4-(4-fluorophenyl)-2-(methylsulfanyl)-1H-imidazol-5-yl]pyridin-2-yl}amino)-4-methoxyphenyl]propanamide
ChemComp-QQM: N-[3-({4-[4-(4-fluorophenyl)-2-(3-hydroxypropyl)-1H-imidazol-5-yl]pyridin-2-yl}amino)-4-methoxyphenyl]propanamide
|
|---|
| 由来 | homo sapiens (ヒト)
|
|---|
キーワード | TRANSFERASE/TRANSFERASE inhibitor / egfr / inhibitor / TRANSFERASE / TRANSFERASE-TRANSFERASE inhibitor complex / Epidermal growth factor receptor / cancer |
|---|